Cocrystal Pharma's total assets for Q2 2026 were $4.65M, a decrease of -52.13% from the previous quarter. DE:8CC total liabilities were $3.60M for the fiscal quarter, a 6.63% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.